Chemclin Diagnostics Co., Ltd. (SHA:688468)
China · Delayed Price · Currency is CNY 6.16
-0.01 (-0.16%)
Aug 4, 2026, 3:00 PM CST
Chemclin Diagnostics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 38.33 | 43.91 | 127.07 | 147.37 | 152.63 | 142.76 |
Depreciation & Amortization | 56.33 | 56.33 | 53.7 | 49.29 | 51.21 | 52.98 |
Other Amortization | 5.05 | 5.05 | 4.38 | 3.32 | 3.06 | 4.06 |
Loss (Gain) From Sale of Assets | -0.12 | -0.12 | -0.51 | -0.18 | -0.07 | 0.1 |
Asset Writedown & Restructuring Costs | 3.02 | 3.02 | 4.12 | 2.83 | 2.15 | 2.32 |
Loss (Gain) From Sale of Investments | -10.07 | -10.07 | -11.52 | -14.77 | -19.58 | -12.6 |
Provision & Write-off of Bad Debts | 0.02 | 0.02 | -0.2 | -0.41 | 0.02 | 0.14 |
Other Operating Activities | 20.48 | 5.66 | 7.86 | 1.22 | 1.97 | 1.22 |
Change in Accounts Receivable | 9.35 | 9.35 | 26.76 | 3.82 | 6.82 | 22.39 |
Change in Inventory | -7.5 | -7.5 | -1.34 | 1.12 | 7.95 | -25.15 |
Change in Accounts Payable | -8.24 | -8.24 | -31.44 | -11.55 | 26.11 | 4.6 |
Change in Other Net Operating Assets | - | - | - | - | 17.45 | - |
Operating Cash Flow | 103.13 | 93.9 | 167.95 | 173.05 | 244.56 | 188.86 |
Operating Cash Flow Growth | -29.06% | -44.09% | -2.95% | -29.24% | 29.49% | 24.29% |
Capital Expenditures | -41.12 | -69.88 | -107.49 | -301.37 | -125.28 | -72.55 |
Sale of Property, Plant & Equipment | 0.96 | 0.37 | 0.22 | 0.03 | 0.02 | 0.04 |
Investment in Securities | -11 | -26 | -39 | -22 | -10 | -252 |
Other Investing Activities | 7.38 | 9.37 | 12.21 | 15.66 | 20.76 | 13.97 |
Investing Cash Flow | -43.78 | -86.14 | -134.06 | -307.68 | -114.5 | -310.54 |
Long-Term Debt Issued | - | - | 23.71 | 196.48 | - | - |
Long-Term Debt Repaid | - | -29.64 | -8.12 | -13.33 | -11.78 | -11.09 |
Net Debt Issued (Repaid) | -29.64 | -29.64 | 15.59 | 183.16 | -11.78 | -11.09 |
Issuance of Common Stock | - | - | 0.85 | - | - | 261.35 |
Repurchase of Common Stock | - | - | -51.09 | - | - | - |
Common Dividends Paid | -54.52 | -54.79 | -53.28 | -139.15 | -68.17 | - |
Other Financing Activities | 1.19 | -13.87 | - | - | - | -8.26 |
Financing Cash Flow | -82.98 | -98.3 | -87.93 | 44.01 | -79.95 | 242 |
Foreign Exchange Rate Adjustments | -0.18 | -0.11 | 0.07 | 0.08 | 0.4 | -0.1 |
Net Cash Flow | -23.79 | -90.65 | -53.97 | -90.54 | 50.51 | 120.22 |
Free Cash Flow | 62.01 | 24.01 | 60.46 | -128.32 | 119.28 | 116.31 |
Free Cash Flow Growth | 2.96% | -60.28% | - | - | 2.55% | 69.43% |
Free Cash Flow Margin | 19.10% | 7.22% | 13.86% | -28.81% | 25.64% | 24.71% |
Free Cash Flow Per Share | 0.15 | 0.06 | 0.15 | -0.32 | 0.30 | 0.30 |
Levered Free Cash Flow | -171.9 | -28.63 | 10.56 | -169.54 | 93.29 | 57.47 |
Unlevered Free Cash Flow | -168.08 | -24.62 | 13.84 | -169.25 | 93.61 | 57.93 |
Cash Income Tax Paid | 35.36 | 40.49 | 69.87 | 96.57 | 62.9 | 62.44 |
Change in Working Capital | -9.91 | -9.91 | -16.95 | -15.62 | 53.18 | -2.12 |